Publications by authors named "Lew Barker"

Claim this Profile
S
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial.
Daniel F Hoft, Azra Blazevic, Asmir Selimovic, Aldin Turan, Jan Tennant, Lew Barker

EBioMedicine· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
Helen A Fletcher, Rachel Tanner, Robert S Wallis, Joel Meyer, Zita-Rose Manjaly, Lew Barker

Clin Vaccine Immunol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventive vaccines for tuberculosis.
Thomas G Evans, Michael J Brennan, Lew Barker, Jelle Thole

Vaccine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational approach to selection and clinical development of TB vaccine candidates.
Lew Barker, Luc Hessel, Barry Walker

Tuberculosis (Edinb)· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial.
Anthony Hawkridge, Mark Hatherill, Francesca Little, Margaret Ann Goetz, Lew Barker

BMJ· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Joyce M Gonin, Hien Nguyen, René Gonin, Avina Sarna, Anne Michels, Lew F Barker

J Nephrol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis